Welcome to our dedicated page for Caring Brands SEC filings (Ticker: CABR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Caring Brands files regular SEC disclosures that reveal how its wellness consumer products business operates financially and strategically. The company's 10-K annual reports detail revenue breakdowns between OTC healthcare products and cosmetics, providing insight into which product categories drive growth and profitability. For consumer goods companies, these filings often disclose critical information about retail partnerships, inventory levels, and product development investments that shape future revenue potential.
Quarterly 10-Q filings track Caring Brands' performance across reporting periods, showing seasonal patterns in consumer demand, the impact of new product launches, and changes in operating expenses. Investors analyzing wellness consumer products companies typically focus on gross margins, marketing expenditures, and distribution costs revealed in these reports. Form 4 filings disclose insider transactions, indicating when executives and directors buy or sell shares, which can signal confidence in the company's direction.
Material events affecting Caring Brands appear in 8-K filings, which document significant business developments such as major distribution agreements, regulatory actions, or changes in product strategy. For a Nasdaq-listed consumer products company, proxy statements (DEF 14A) provide transparency into executive compensation structures and governance practices. Our platform's AI assistance helps investors quickly locate relevant sections within these filings, whether tracking insider buying patterns through Form 4 documents or analyzing segment performance in quarterly reports.
This comprehensive SEC filings archive gives investors the regulatory disclosures needed to evaluate Caring Brands' financial health, operational strategy, and management decisions in the competitive wellness consumer goods market.
Caring Brands, Inc. reported that director Hector W. Alila received a grant of stock options to purchase 25,000 shares of common stock at an exercise price of
The options vested immediately on the grant date and are scheduled to expire on
Caring Brands, Inc. reported an insider equity award involving a director who is also a 10% owner. On December 11, 2025, the board, following a recommendation from the compensation committee, approved a grant of 100,000 stock options under the company’s equity incentive plan, with an exercise price of $1.243 per share and no cost to acquire the options themselves.
The options are scheduled to fully vest on June 11, 2026, provided the reporting person continues to serve the company, and they are set to expire on December 11, 2030. After this transaction, the reporting person beneficially owns 100,000 stock options and also holds 2,000,000 shares of Caring Brands common stock.
Caring Brands, Inc. director Christopher Melton reported receiving a stock option grant from the company. On December 11, 2025, the board of directors, following a recommendation from the compensation committee, approved an option for Melton to buy 25,000 shares of common stock at an exercise price of $1.13 per share under the company’s equity incentive plan.
The options vested immediately on December 11, 2025 and expire on December 11, 2030. Following this grant, Melton beneficially owns 25,000 stock options directly.
Caring Brands, Inc. director Christopher Matthew Galeta received a stock option grant on December 11, 2025 under the company’s equity incentive plan. The award covers 25,000 stock options with an exercise price of $1.13 per share, giving him the right to buy 25,000 shares of common stock at that price.
The options were approved by the Board of Directors at the recommendation of the Compensation Committee and vest immediately as of December 11, 2025. After this grant, Galeta beneficially owns 25,000 derivative securities in the form of these stock options, which expire on December 11, 2030.
Caring Brands, Inc. disclosed that its Chief Executive Officer, director, and 10% owner, Dr. Glynn Wilson, received two restricted stock unit (RSU) grants of common stock on December 11, 2025 under the company’s equity incentive plan. The first award covers 126,720 RSUs that fully vest on June 11, 2026, and the second covers 45,872 RSUs that fully vest on December 11, 2026, in each case conditioned on Dr. Wilson’s continued service with the company.
Both grants are shown at a price of $0 per share, reflecting equity compensation rather than an open‑market purchase. Following these awards, Dr. Wilson is reported as beneficially owning 2,172,592 shares of Caring Brands common stock, which includes his prior ownership of 2,000,000 shares.
Caring Brands, Inc. reported that Chief Financial Officer Tyler Thomas Moore received equity awards totaling 300,000 restricted stock units of common stock on December 11, 2025 under its equity incentive plan.
The grants consist of 270,000 restricted stock units that fully vest on June 11, 2026 and 30,000 restricted stock units that fully vest on December 11, 2026, in each case subject to his continued service with the company. Following these awards, he beneficially owns 300,000 shares of common stock directly.
FAQ
What is the current stock price of Caring Brands (CABR)?
What is the market cap of Caring Brands (CABR)?
